A development-stage pharmaceutical company focused on the acquisition, development and commercialization of prescription drugs for the treatment of drug addiction.


Updates from The Motley Fool

Latest updates on Catalyst Pharmaceuticals from Fool.com.
This Week in Biotech: Part 2

Consider this the continuation of what's been an incredibly busy week for biotech companies in te...



Stock Performance

View Interactive CPRX Charts
Sponsored by

Key Data Points

Primary metrics and data points about Catalyst Pharmaceuticals.
Current Price: $1.18
Prev Close: $1.15
Open: $1.15
Bid: $1.16
Ask: $1.20
Day's Range: $1.15 - $1.20
52wk Range: $0.51 - $3.00
Volume: 367,065
Avg Vol 601,151
Market Cap: $98M
P/E (ttm): -4.79
EPS (ttm): ($0.24)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Catalyst Pharmaceuticals.
CAPS Rating 2 out of 5
 
59 Outperform
10 Underperform
CAPS All Stars
 
4 Outperform
1 Underperform

How do you think Catalyst Pharmaceuticals will perform against the market?



You pick for Catalyst Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Catalyst Pharmaceuticals.

A development-stage pharmaceutical company focused on the acquisition, development and commercialization of prescription drugs for the treatment of drug addiction.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers